Intarcia Therapeutics (United States)
Intarcia Therapeutics is an American biopharmaceutical company based in Boston, MA and incorporated under the laws of Delaware. It was founded in 1995 under the name "BioMedicines" and changed to its present name in 2004. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Intarcia Therapeutics (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
67%
Total
Publications
162
Total Open
Publications
108
Total
Citations
5.9K
Open Access
Percentage
67%
Total
Publications
162
Total Open
Publications
108
Total
Citations
5.9K
Breakdown
Publisher Open
17%
Both
34%
Other Platform Open
15%
Closed
34%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 42%
34
Hybrid 28%
22
No Guarantees 30%
24
Other Platform Open
Domain 74%
57
Institution 43%
33
Preprint 22%
17
Other Internet 6%
5
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 57 |
doaj.org OAI-PMH Repository | Institution | 21 |
bioRxiv | Preprint | 13 |
LA Referencia | Institution | 5 |
Unknown Repository | Other Internet | 4 |
Royal Netherlands Academy of Arts and Sciences | Institution | 3 |
Office of Scientific and Technical Information | Institution | 3 |
medRxiv | Preprint | 3 |
Massachusetts Institute of Technology | Institution | 2 |
Europe PMC | Domain | 2 |